[
    {
        "題別": "複",
        "題號": "1",
        "題目": "若是乳房X光攝影中，發現有一棘狀腫瘤（Spiculated mass）時，除了是乳癌之外，另外有下列何種可能性？",
        "選項": [
            "A. 輻射狀疤（radial scar）",
            "B. 脂肪壞死（fat necrosis）",
            "C. 膿瘍（abscess）",
            "D. 血塊（hematoma）",
            "E. 切片手術後疤痕"
        ],
        "答案": "ABCDE",
        "出處": "Diagnostic Breast Imaging, p248"
    },
    {
        "題別": "複",
        "題號": "2",
        "題目": "下列何種疾病可能併發男性女乳症（gynecomastia）？",
        "選項": [
            "A. Germ cell tumors",
            "B. Hyperthyroidism",
            "C. Hypothyroidism",
            "D. 肝臟疾病",
            "E. Orchitis"
        ],
        "答案": "ABCDE",
        "出處": "The Breast-----Comprehensive\nManagement of Benign and\nMalignant Diseases, 2nd ed., p157-\n163"
    },
    {
        "題別": "複",
        "題號": "3",
        "題目": "有關Phyllodes tumor的陳述，下列何者有誤？",
        "選項": [
            "A. 好發於35～55歲之女性",
            "B. Estrogen receptor常呈陽性",
            "C. 即使長的很大，也不易固定於胸壁上",
            "D. 通常做wide local excision或simple mastectomy即可",
            "E. 轉移的病灶常含epithelial component"
        ],
        "答案": "BE",
        "出處": "The Breast-----Comprehensive\nManagement of Benign and\nMalignant Diseases, 2nd ed.,\np243,317-318"
    },
    {
        "題別": "複",
        "題號": "4",
        "題目": "一位85歲女性在右側乳房有一無症狀柔軟的大腫塊， mammography上可見12x12公分encapsulated radiolucent circular lesion with central calcification，以下敘述何者正 確？",
        "選項": [
            "A. circular lesion通常是benign lesion",
            "B. circular lesion通常是malignant lesion",
            "C. 最有可能的診斷為cyst",
            "D. 最有可能的診斷為lipoma",
            "E. calcification為malignant lesion所特有"
        ],
        "答案": "AD",
        "出處": "Teaching atlas of mammography 3rd\nrevised and enlarged edition, p21"
    },
    {
        "題別": "複",
        "題號": "5",
        "題目": "對於發炎性乳癌（Inflammatory breast cancer）的敘述， 何者為錯：",
        "選項": [
            "A. 真皮層淋巴之癌侵犯是診斷所必需",
            "B. 約佔乳癌患者的10-15﹪",
            "C. 平均罹病年齡與一般乳癌患者差不多",
            "D. 與預後最相關者為腋窩淋巴有否轉移及轉移程度",
            "E. 60﹪的患者於診斷時即已有遠處轉移"
        ],
        "答案": "AB",
        "出處": "The Breast, 2nd edition, p1278"
    },
    {
        "題別": "複",
        "題號": "6",
        "題目": "一位22歲女性因左乳發現一顆兩公分硬塊求診，下列何項 影像檢查為不適當的初步檢查？",
        "選項": [
            "A. 乳房X光攝影",
            "B. 乳房核磁造影檢查",
            "C. 乳房核醫同位素掃描",
            "D. 乳房超音波檢查",
            "E. 乳房電腦斷層攝影"
        ],
        "答案": "ABCE",
        "出處": "Grainger & Allison’s Diagnostic\nRadiology 3rd ed. Vol. 3, p2020"
    },
    {
        "題別": "複",
        "題號": "7",
        "題目": "決定是否在乳癌手術後做輔助性化學治療時，下列哪些項 目不是考慮的重點？",
        "選項": [
            "A. 病人罹病年齡",
            "B. 腫瘤位置",
            "C. 荷爾蒙接受體陽性與否",
            "D. 淋巴轉移與否",
            "E. 手術為改良型全乳根除或是乳房保留手術"
        ],
        "答案": "BE",
        "出處": "Disease of the breast by Jay R.\nHarris. 2nd ed. 2000, p599-603"
    },
    {
        "題別": "複",
        "題號": "8",
        "題目": "下列有關各種乳癌輔助性荷爾蒙治療的敘述何者正確？",
        "選項": [
            "A. Tamoxifen屬於SERM (selective estrogen receptor modulater)的一種",
            "B. Tamoxifen不建議使用於ER(-)且PR(-)患者",
            "C. Goserelin的作用是屬於chemical ovarian ablation",
            "D. Aminoglutethimide是aromatase inhibitor的一種",
            "E. Aminoglutethimide可降低血ER濃度，多用於停經前患者"
        ],
        "答案": "ABCD",
        "出處": "Disease of the breast by Jay R.\nHarris. 2nd ed. 2000, p617-618"
    },
    {
        "題別": "複",
        "題號": "9",
        "題目": "下列有關乳癌骨骼轉移（Bone metastases）的敘述哪些是 正確的？",
        "選項": [
            "A. 臨床表現多為疼痛或病理性骨折（pathological fracture）",
            "B. 血鈣濃度升高",
            "C. 病人若出現骨骼轉移預後極差，絕大多數都在兩年內死 亡",
            "D. 可出現骨髓抑制（myelosuppression）現象",
            "E. 骨骼掃描（bone scan）除了可以診斷骨骼轉移，也是評 估治療後的成效的良好工具"
        ],
        "答案": "ABD",
        "出處": "Textbook of Breast Cancer by\nBonadonn 1997, p155"
    },
    {
        "題別": "複",
        "題號": "10",
        "題目": "下列有關發炎性乳癌的敘述何者為是？",
        "選項": [
            "A. 發炎性乳癌在TNM分類上屬於T4病灶",
            "B. 多屬分化良好型乳管細胞癌（well-differentiated ductal cancer）",
            "C. 荷爾蒙接受體（ER, PR）多呈陰性",
            "D. 即乳癌腫瘤大至某一程度引起之細菌感染（secondary infection）",
            "E. 治療後局部復發率較一般乳癌高很多"
        ],
        "答案": "ACE",
        "出處": "Disease of the breast by Jay R.\nHarris. 2nd ed. 2000, p650"
    },
    {
        "題別": "複",
        "題號": "11",
        "題目": "懷孕相關的乳癌具下列諸特性中何者為非？",
        "選項": [
            "A. 預後較差",
            "B. 淋巴轉移的比例較低",
            "C. 腫瘤大於2公分者較少",
            "D. 診斷時期數較晚",
            "E. 乳腺因懷孕的變化會影響診斷"
        ],
        "答案": "ABC",
        "出處": "Diseases of the Breast, 2nd ed.,\nEdited by Ray R. Harris. Lippincott\n2000, p691-699"
    },
    {
        "題別": "複",
        "題號": "12",
        "題目": "有關懷孕期間診斷出來的乳癌，下列處置何者為非？",
        "選項": [
            "A. Breast conservation surgery是最好的local management",
            "B. 放射治療在任何trimester皆可做",
            "C. 治療性流產的效果不確定，但對晚期的病患可使治療單 純化",
            "D. 化療在早期懷孕時應避免",
            "E. 輔助性化療最安全的藥物為cyclophosphamide加 doxorubicin"
        ],
        "答案": "AB",
        "出處": "Diseases of the Breast, 2nd ed.,\nEdited by Ray R. Harris. Lippincott\n2000, p691-699"
    },
    {
        "題別": "複",
        "題號": "13",
        "題目": "有關男性乳癌，下列何者為錯？",
        "選項": [
            "A. 發生比率約女性的1/100",
            "B. 好發年齡比女性早10歲",
            "C. 近年來發生率有增加的趨勢",
            "D. ER, PR receptor陽性的比例高於女性乳癌",
            "E. Lobular carcinoma較少見"
        ],
        "答案": "BCD",
        "出處": "Diseases of the Breast, 2nd ed.,\nEdited by Ray R. Harris. Lippincott\n2000, p661-665"
    },
    {
        "題別": "複",
        "題號": "14",
        "題目": "懷孕與非懷孕的乳癌患者哪些是正確的？",
        "選項": [
            "A. difficult to have early diagnosis in pregnant patients",
            "B. poorly survival rate in pregnant patients",
            "C. the treatment protocal is similar in two groups",
            "D. conservative surgery is not contraindicated in two groups",
            "E. immediate abortion is indicated when diagnosis is set up"
        ],
        "答案": "AD",
        "出處": "Principles of Surgery 7th ed, p592"
    },
    {
        "題別": "複",
        "題號": "15",
        "題目": "有關乳頭分泌物（nipple discharge）的敘述，下列何者正 確？",
        "選項": [
            "A. 自動流出的分泌物（spontaneous discharge）較無意義",
            "B. 單側的分泌物較有意義",
            "C. 分泌物不一定是血性（bloody）",
            "D. 綠色（green）分泌物常是乳癌的跡象",
            "E. 只有乳頭分泌物而無乳房腫塊，會是乳癌的機會其實不 高"
        ],
        "答案": "BCE",
        "出處": "The Breast, Bland & Copeland. 2nd\ned. W.B Saunders, p616"
    },
    {
        "題別": "複",
        "題號": "16",
        "題目": "有關乳房手術切片（open biopsy）的敘述，下列何者正 確？",
        "選項": [
            "A. 切除切片（excisional biopsy）常連帶一層正常乳房組織 之邊緣切除",
            "B. 做切除切片時皮膚應沿著Langer’s lines切開",
            "C. 切除切片大多可在局部麻醉下進行",
            "D. 切開切片（incisional biopsy）最好能取出1mg以上的腫 瘤組織",
            "E. 觸摸不到的病灶無法做手術切片（open biopsy）"
        ],
        "答案": "ACD",
        "出處": "The Breast, Bland & Copeland. 2nd\ned. W.B Saunders, p621"
    },
    {
        "題別": "複",
        "題號": "17",
        "題目": "有關乳房細針抽吸（fine needle aspiration）的敘述，下列 何者正確？",
        "選項": [
            "A. 合併採用理學檢查（physical examination）、乳房攝影 （mammography）與細針抽吸，可使乳癌診斷的正確率接 近百分之百",
            "B. 單就細針抽吸而言，其敏感度（sensitivity）約有60﹪",
            "C. 所採用的細針頭，會導致癌細胞長到針經路徑（tumor growing out of the needle tract）的機會其實很小",
            "D. 細針抽吸不會引起血腫（hematoma）的併發症",
            "E. 做完細針抽吸最好要經過2星期以上才可做乳房攝影（ mammography）"
        ],
        "答案": "ACE",
        "出處": "The Breast, Bland & Copeland. 2nd\ned. W.B Saunders, p706"
    },
    {
        "題別": "複",
        "題號": "18",
        "題目": "乳房無硬塊之Paget's disease之敘述，以下何者為正確？",
        "選項": [
            "A. Paget's disease of Nipple意味著in situ carcinoma within the nipple",
            "B. Paget's disease經常會伴有乳頭的濕疹，搔癢及脫屑",
            "C. Paget's disease is an epidermotropic carcinoma which is originate in the ducts",
            "D. Paget's disease大部份侵犯雙側的乳頭",
            "E. Paget's disease需作標準腋下淋巴摘除術"
        ],
        "答案": "ABC",
        "出處": "Disease of Breast (Joy.R.Harris),\np870-874"
    },
    {
        "題別": "複",
        "題號": "19",
        "題目": "Breast cancer之發生率最高在外上方，其原因下列何者為 誤？",
        "選項": [
            "A. 距離血管最近",
            "B. 距離淋巴最近",
            "C. 乳管最發達",
            "D. 乳房組織最多",
            "E. 不易發現"
        ],
        "答案": "ABCE",
        "出處": "Diseases of the Breast 2nd edition,\n2000, p411"
    },
    {
        "題別": "複",
        "題號": "20",
        "題目": "有關Breast cancer distant metastasis，常見之處？",
        "選項": [
            "A. Bone",
            "B. Lung",
            "C. Liver",
            "D. Stomach",
            "E. Ovary"
        ],
        "答案": "ABC",
        "出處": "Diseases of the Breast 2nd edition,\n2000, p561"
    },
    {
        "題別": "複",
        "題號": "21",
        "題目": "關於Gynecomastia，下列何者正確？",
        "選項": [
            "A. 多發生於young male",
            "B. Age>50，亦常見",
            "C. 大多不需手術治療",
            "D. 藥物治療有效",
            "E. 需和男性乳癌作區分"
        ],
        "答案": "ABCE",
        "出處": "Sabiston’s Textbook of surgery\n16th edition, p559"
    },
    {
        "題別": "複",
        "題號": "22",
        "題目": "有關乳頭分泌物，下列何者正確？",
        "選項": [
            "A. 乳頭分泌液體為常見症狀",
            "B. 藥物可引起乳頭分泌",
            "C. Milk like分泌物稱為galactorrhea",
            "D. Bloody discharge最常見的原因是intraductal papilloma",
            "E. Bloody discharge最常見的原因是intraductal carcinoma"
        ],
        "答案": "ABCD",
        "出處": "Sabiston’s Textbook of surgery\n16th edition, p559-560"
    },
    {
        "題別": "複",
        "題號": "23",
        "題目": "有關Breast cancer distant metastasis最常見之三處為？",
        "選項": [
            "A. Ovary",
            "B. Brain",
            "C. Liver",
            "D. Lung",
            "E. Bone"
        ],
        "答案": "CDE",
        "出處": "Disease of the Breast 2nd ed. 2000,\nJR Harris et al ed., p421"
    },
    {
        "題別": "複",
        "題號": "24",
        "題目": "Paget's disease之描述，何者為非？",
        "選項": [
            "A. 徵狀像乳頭皮膚病",
            "B. 為乳頭癌前期病變，局部切除即可",
            "C. 為早期癌病灶之乳頭侵犯，即使有合併腫瘤也甚少有腋 下淋巴腺轉移",
            "D. 為癌病灶之乳頭侵犯，常有腋下淋巴腺轉移",
            "E. 為晚期癌病灶合併乳頭侵犯，癒後很差"
        ],
        "答案": "BCE",
        "出處": "Principle of Surgery, p563"
    },
    {
        "題別": "複",
        "題號": "25",
        "題目": "下列何者為改良式乳癌根除手術的常見的術後併發症？",
        "選項": [
            "A. 前胸及腋下皮膚感覺異常",
            "B. 傷口感染",
            "C. 傷口積液（seroma formation）",
            "D. 皮瓣壞死",
            "E. 上肢肌肉無力"
        ],
        "答案": "ABCD",
        "出處": "Disease of the breast by Jay R.\nHarris. 2nd ed. 2000, p532-533"
    },
    {
        "題別": "複",
        "題號": "26",
        "題目": "下列何種乳癌病人不適合接受乳房保留手術（breast- conserving surgery）？",
        "選項": [
            "A. 懷孕初期早期乳癌",
            "B. 同時有二個病灶在內側及外側",
            "C. 乳房攝影顯示有廣泛分散之惡性鈣化病灶",
            "D. 患側胸部曾經接受過放射治療",
            "E. 病灶接近腋下"
        ],
        "答案": "ABCD",
        "出處": "Disease of the breast by Jay R.\nHarris. 2nd ed. 2000, p525-526"
    },
    {
        "題別": "複",
        "題號": "27",
        "題目": "下列那一項關於乳房自我檢查的敘述是正確的？",
        "選項": [
            "A. 檢查應包括乳房、腋下及頸部淋巴結區域",
            "B. 停經前婦女最好檢查時間為週期前一週，較容易摸到腫 塊",
            "C. 停經後婦女可固定每月同一天檢查",
            "D. 每位女性應從20歲即開始每月自我檢查",
            "E. 有任何異樣感應即到醫院檢查"
        ],
        "答案": "ACDE",
        "出處": "The Breast, 2nd edition, p617"
    },
    {
        "題別": "複",
        "題號": "28",
        "題目": "有關乳房疾病-Mondor's Disease之敘述何者正確？",
        "選項": [
            "A. 臨床上表現急性痛，尤其在乳部側面或前胸處",
            "B. 這種病約經2到6週左右會自行改善",
            "C. 引起之原因不明",
            "D. 這種病不經治療會更惡化",
            "E. 通常侵犯前胸及腹壁表淺靜脈，而引起靜脈發炎"
        ],
        "答案": "ABCE",
        "出處": "Principle of Surgery SCHWARTZ,\np548"
    },
    {
        "題別": "複",
        "題號": "29",
        "題目": "有關乳癌的描述下列何者不正確？",
        "選項": [
            "A. 先前一側乳癌，其另一側得乳癌的機會與平常人相似",
            "B. 罹患乳癌者其子宮頸癌機率上升",
            "C. 母親及姊妹均得乳癌之女性，她罹患乳癌的機率為常人 的15倍以上",
            "D. 曾餵母乳三個月之女性得乳癌的機會是常人的一半",
            "E. 40歲前做雙側卵巢切除者其罹患乳癌的機會比常人多一 倍"
        ],
        "答案": "ABDE",
        "出處": "Textbook of Surgery, Sabiston, p542"
    },
    {
        "題別": "複",
        "題號": "30",
        "題目": "有關乳癌細胞動情激素接受體（ER）及黃體激素接受體（ PR）的描述何者為是？",
        "選項": [
            "A. 原發乳癌及轉移乳癌之ER陽性率大致相同",
            "B. PR是estrogen dependent",
            "C. 停經前的婦女ER陽性率較低",
            "D. ER及PR皆為陽性其內分泌治療有效率約為80﹪",
            "E. 所有各型乳癌的ER陽性率皆相同"
        ],
        "答案": "ABCD",
        "出處": "Principle of Surgery, p582"
    },
    {
        "題別": "複",
        "題號": "31",
        "題目": "有關乳癌發生在懷孕期間之敘述，何者為非？",
        "選項": [
            "A. 同一期別的乳癌,懷孕時期發生之乳癌比非懷孕時期之預 後為差",
            "B. 懷孕時期發生之乳癌腫瘤通常較不容易早期診斷出來",
            "C. 乳房攝影檢查（Mammography）是禁止使用在疑似乳 癌之懷孕婦女",
            "D. 細針穿吸法（Fine-Needle Aspiration）不可穿吸在懷孕 婦女之乳部腫塊上",
            "E. 此種病患若有淋巴腺轉移，則於任何懷孕期（Trimester of pregnancy）皆可接受抗癌化學藥物治療"
        ],
        "答案": "ACDE",
        "出處": "Principle of Surgery SCHWARTZ,\np586-587"
    },
    {
        "題別": "複",
        "題號": "32",
        "題目": "有關遺傳性乳癌的描述下列何者為正確？",
        "選項": [
            "A. 遺傳性乳癌的第一型基因（BRCA1）是位於第17對染色 體的長臂",
            "B. 帶有第一型乳癌基因（BRCA1）變異者在80歲前約60- 80﹪會發展成乳癌",
            "C. 第一型乳癌基因（BRCA1）變異在東歐猶太人以185del AG變異最常見",
            "D. 約有一半的遺傳性乳癌與BRCA1基因變異有關",
            "E. BRCA1基因變異只有在西方人才發現"
        ],
        "答案": "ABCD",
        "出處": "The Breast, Bland & CopelandⅢ,\n2nd ed. 1998, p345"
    },
    {
        "題別": "複",
        "題號": "33",
        "題目": "有關纖維腺瘤（Fibroadenoma）之敘述何者為非？",
        "選項": [
            "A. 典型的纖維腺瘤通常長到二到三公分左右則停止生長",
            "B. 纖維腺瘤的診斷不能靠細針穿刺及細胞檢查技術（Fine- needle Aspiration）",
            "C. 已有定論,這種腺瘤不經切除會演變成葉狀瘤（ Phyllodes Tumor）",
            "D. 典型纖維腺瘤的病人比一般正常人有較高比率會有乳癌 發生",
            "E. 三十五歲以上婦女伴有纖維腺瘤，不會建議手術切除"
        ],
        "答案": "BCDE",
        "出處": "Principle of Surgery SCHWARTZ,\np550"
    },
    {
        "題別": "複",
        "題號": "34",
        "題目": "乳房超音波下，下列何種情形會在病變處後方呈現Acoustic Shadow？",
        "選項": [
            "A. 粗大鈣化點",
            "B. 鈣化纖維腺瘤",
            "C. 鈣化油狀囊腫（calcified oil cyst）",
            "D. 乳癌",
            "E. 單純囊腫（Simple cyst）"
        ],
        "答案": "ABCD",
        "出處": "Diagnostic Breast Imaging, p90"
    },
    {
        "題別": "複",
        "題號": "35",
        "題目": "下列何者屬於乳癌相對高危險因素？",
        "選項": [
            "A. 社會經濟地位高",
            "B. 頭胎小於30歲",
            "C. 母親罹患乳癌",
            "D. 早來初經",
            "E. 生產過女性"
        ],
        "答案": "ACD",
        "出處": "Principle of Surgery, Schwartz, 6th\ned, p555"
    },
    {
        "題別": "複",
        "題號": "36",
        "題目": "下列皆為決定乳癌癒後的因素，其中最具決定性的兩個因 子是：",
        "選項": [
            "A. 癌病灶的體積",
            "B. 腋下淋巴腺的有無轉移及轉移數目",
            "C. 動情激素接受體的陽性與否",
            "D. 癌細胞分裂指數",
            "E. 致癌基因的有無"
        ],
        "答案": "AB",
        "出處": "Principle of Surgery, p584-585"
    },
    {
        "題別": "複",
        "題號": "37",
        "題目": "以下哪種病人較不適合接受乳房保留手術（breast- conserving surgery）？",
        "選項": [
            "A. 5年前得右側乳癌，本月發現左外側1公分大小之乳癌",
            "B. 懷孕10周的婦女，1公分乳癌及腋下淋巴轉移",
            "C. 單側乳房多發性乳癌",
            "D. 1公分之乳房內上側之乳癌",
            "E. 曾經接受過乳房保留手術加放射治療後，局部復發1公分 大小"
        ],
        "答案": "BCE",
        "出處": "Disease of the breast by Jay R.\nHarris. 2nd ed. 2000, p526"
    },
    {
        "題別": "複",
        "題號": "38",
        "題目": "以下哪些物質為常被用於尋找Sentinel LN of breast cancer？",
        "選項": [
            "A. Methylene blue",
            "B. Barium",
            "C. I-131",
            "D. 99mTC",
            "E. Lipoidol"
        ],
        "答案": "AD",
        "出處": "The Sentinel Node in Surgical\nOncology, p5"
    },
    {
        "題別": "複",
        "題號": "39",
        "題目": "乳癌Breast conservative surgery的描述有哪幾項為非？",
        "選項": [
            "A. 術前患者腋下有明顯腋下淋巴腺腫大者可接受化療之後 再接受此手術",
            "B. 依癌病灶的體積再決定腋下淋巴腺是否清除",
            "C. 癌病灶切除後的乳房必須接放射治療",
            "D. 因有放射治療所以癌病灶只要切除大部份即可",
            "E. 癌病灶的體積不是決定是否適合做此手術的因素"
        ],
        "答案": "BDE",
        "出處": "Principle of Surgery, p576-578"
    },
    {
        "題別": "複",
        "題號": "40",
        "題目": "下列敘述何者為正確?",
        "選項": [
            "(A). Neoadjuvant therapy provides better treatment outcome compared with conventional adjuvant therapy because it can treat the micro-metastasis earlier.",
            "(B). Neoadjuvant chemotherapy was pioneered in the setting of LABC ( locally advanced breast cancer ) as first reported in the 1970s.",
            "(C). Aromatase inhibitors can be used for both pre- menopausal and post-menopausal hormonal receptor positive breast cancer patients.",
            "(D). Tamoxifen use, much as with estrogen therapy, is clearly related to an increased incidence of endometrial cancer.",
            "(E). Toxicity of tamoxifen include menopausal symtoms, sexual dysfunction, ocular toxicity, thromboembolic and hematologic toxicity."
        ],
        "答案": "BDE",
        "出處": "Disease of the breast 4th edition\n2010"
    },
    {
        "題別": "複",
        "題號": "41",
        "題目": "關於乳房篩檢，以下何者會建議用乳房核磁共振MRI檢查？",
        "選項": [
            "(A). BRCA mutation",
            "(B). First-degree relative of BRCA carrier but untested",
            "(C). Radiation to chest between ages 10 and 30",
            "(D). Women at less than 15% lifetime risk",
            "(E). Axillary node malignancy and unknown site of primary tumor"
        ],
        "答案": "ABCE",
        "出處": "Disease of the Breast, 4th e,\nP104,159"
    },
    {
        "題別": "複",
        "題號": "42",
        "題目": "針對乳房疑似病兆以影像導引粗針穿刺檢查比手術切片檢 查來得不侵犯性，然而針對粗針穿刺檢查結果為高風險病 兆時，手術切除是必要的。以下幾種病理報告屬於高風險 病兆？Imaging-guided core needle biopsy (CNB) is a less invasive and less expensive alternative to surgical biopsy for the evaluation of breast lesions. Surgical excision after CNB diagnosis of high-risk breast lesion is warranted. Which pathologic finding below suggest high-risk breast lesion?",
        "選項": [
            "A. Papillary lesions",
            "B. Radial scar",
            "C. ADH (atypical ductal hyperplasia)",
            "D. ALH (atypical lobular hyperplasia)",
            "E. Fibrocystic change"
        ],
        "答案": "ABCD",
        "出處": "Mayo Clin Proc. 2014\nApr;89(4):536-47. (IF:5.92);\nDisease of the Breast, 4th e, p201-\n202"
    },
    {
        "題別": "複",
        "題號": "43",
        "題目": "關於乳癌之期別定義，如果腫瘤侵犯到以下何部位屬於遠 處轉移？ About the staging the breast cancer, if the tumor involve these area lymph nodes are classified as metastasis:",
        "選項": [
            "A. Level III lymph nodes",
            "B. Internal mammary (ipsilateral) lymph nodes",
            "C. Ipsilateral supraclavicular lymph nodes",
            "D. Cervical lymph nodes",
            "E. Contralateral internal mammary lymph nodes."
        ],
        "答案": "DE",
        "出處": "Disease of the Breast, 4th e, p490"
    },
    {
        "題別": "複",
        "題號": "44",
        "題目": "關於乳房乳管原位癌(DCIS)的敘述何者有誤？",
        "選項": [
            "A. DCIS 是heterogeneous lesions,所以病人的考量與需求 不該列入治療決策考量",
            "B. mammography應用於乳癌篩檢與乳房檢查後, DCIS已佔 新診斷乳癌個案的60%以上",
            "C. 施行excision only的病人 後續局部復發為invasive cancer的機率遠高於excison 再加以放射線治療(WBRT)的 病人",
            "D. 乳房部分切除術後再加上放射線治療(WBRT),約可減少 50%的局部復發",
            "E. 施行乳房部分切除時, 術中放射線治療(IORT)對於high grade或diffuse microcalcification的DCIS與傳統放射線治療 (WBRT)相比較,有較好的局部控制"
        ],
        "答案": "ABCE",
        "出處": "The Breast 5th edition; 562- 574"
    },
    {
        "題別": "複",
        "題號": "45",
        "題目": "下列何種因素可用來評估DCIS施行乳房部分切除術後的局 部復發？",
        "選項": [
            "A. nuclear grade",
            "B. the presence of comedo-type necrosis",
            "C. tumor size",
            "D. margin width",
            "E. age"
        ],
        "答案": "ABCDE",
        "出處": "The Breast 5th edition; 562- 574"
    },
    {
        "題別": "複",
        "題號": "46",
        "題目": "下列何者是用來評估乳癌病患可否施行乳房部分切除術的 重要因素？",
        "選項": [
            "A. patient age",
            "B. tumor size",
            "C. gross multifocal/multicentric disease",
            "D. race",
            "E. genetic factor"
        ],
        "答案": "ABCE",
        "出處": "The Breast 5th edition; 695- 697"
    },
    {
        "題別": "複",
        "題號": "47",
        "題目": "關於乳癌病人施行mastectomy後發生locoregional recurrence的敘述何者有誤？",
        "選項": [
            "A. adjuvant systemic treatment可有效減少發生",
            "B. locoregional recurrence後並不會增加遠處器官轉移",
            "C.最常發生的位置是同側的infraclavicular lymph node",
            "D. 發生的位置是同側的supraclavicular lymph node已是 distant disease",
            "E. higher disease stage, aggressive tumor biology, tumor subtype, and younger age是發生的危險因子"
        ],
        "答案": "BCD",
        "出處": "The Breast 5th edition; 808"
    },
    {
        "題別": "複",
        "題號": "48",
        "題目": "關於aromatase inhibitors (Ais)在乳癌治療上主要的副作用 包括下列何者？",
        "選項": [
            "A. hot flashes",
            "B. thromboembolic disease",
            "C. musculoskeletal pain",
            "D. vaginal dryness",
            "E. headache"
        ],
        "答案": "ACDE",
        "出處": "The Breast 5th edition; 911"
    },
    {
        "題別": "複",
        "題號": "49",
        "題目": "下列那些情況是乳房全切除(mastectomy)的絕對適應症？",
        "選項": [
            "(A). Inflammatory breast cancer",
            "(B). Invasive breast cancer with extensive skin or dermal Iymphatic involvement",
            "(C). Patients with a known genetic predisposition to breast cancer",
            "(D). Diffuse suspicious or malignant-appearing microcalcifications",
            "(E). Inability to clear multiple positive pathologic margins after one or more re-excision attempts"
        ],
        "答案": "ABDE",
        "出處": "NCCN Guidelines Version 2.2024\nBINV-G"
    },
    {
        "題別": "複",
        "題號": "50",
        "題目": "乳癌病人接受乳房保留手術(Breast conserving surgery, BCS)對於切除邊界(Margin status)的建議，下列何者正 確？",
        "選項": [
            "(A). Stage I/II invasive breast cancer: no tumor on ink",
            "(B). DCIS with microinvasion: no tumor on ink",
            "(C). Pure DCIS(Ductal carcinoma in situ) : no tumor on ink",
            "(D). Stage I/II invasive breast cancer: at least 2mm",
            "(E). Pure DCIS(Ductal carcinoma in situ) : at least 2mm"
        ],
        "答案": "AE",
        "出處": "NCCN Guidelines Version 2.2024\nBINV-F"
    },
    {
        "題別": "複",
        "題號": "52",
        "題目": "下列那些是早期乳癌病人可能使用到的荷爾蒙治療方式？",
        "選項": [
            "A.(cid:9) Tamoxifen",
            "B.(cid:9) Aromatase inhibitor",
            "C.(cid:9) Fulvestrant",
            "D.(cid:9) Ovarian ablation",
            "E.(cid:9) Ovarian suppression"
        ],
        "答案": "ABDE",
        "出處": "NCCN Guidelines Version 2.2024\nBINV-K"
    },
    {
        "題別": "複",
        "題號": "53",
        "題目": "對於腫瘤大小超過0.5公分，停經後(Post-Menopausal)荷爾 蒙受體陽性Her-2受體陰性的早期乳癌患者，使用Oncotype DX(21-gene RT PCR assay)基因檢測的結果做為是否接受 化學治療的依據，下列敍述何者正確？",
        "選項": [
            "A. Recurrence score ≤ 15，腋下淋巴結没有轉移，應建議 接受化學治療",
            "B. Recurrence score 16-25，腋下淋巴結没有轉移，應建 議接受化學治療",
            "C. Recurrence score ≥ 26，腋下淋巴結没有轉移，應建 議接受化學治療",
            "D. Recurrence score 16-25，1-3顆腋下淋巴結轉移，應建 議接受化學治療",
            "E. Recurrence score ≥ 26，1-3顆腋下淋巴結轉移，應建 議接受化學治療"
        ],
        "答案": "CE",
        "出處": "NCCN Guidelines Version 2.2024\nBINV-6"
    },
    {
        "題別": "複",
        "題號": "54",
        "題目": "對於腫瘤大小超過0.5公分，停經前(Pre-Menopausal)荷爾 蒙受體陽性Her-2受體陰性的早期乳癌患者，使用Oncotype DX(21-gene RT PCR assay)基因檢測的結果做為是否接受 化學治療的依據，下列敍述何者正確？",
        "選項": [
            "A.(cid:9) Recurrence score ≤ 15，腋下淋巴結没有轉移，應建議 接受化學治療",
            "B.(cid:9) Recurrence score ≤ 15，1-3顆腋下淋巴結轉移，應建 議接受化學治療",
            "C.(cid:9) Recurrence score 16-25，1-3顆腋下淋巴結轉移，應建 議接受化學治療",
            "D.(cid:9) Recurrence score ≥ 26，腋下淋巴結没有轉移，應建議 接受化學治療",
            "E.(cid:9) Recurrence score ≥ 26，1-3顆腋下淋巴結轉移，應建 議接受化學治療"
        ],
        "答案": "BCDE",
        "出處": "NCCN Guidelines Version 2.2024\nBINV-7 BINV-8"
    },
    {
        "題別": "複",
        "題號": "55",
        "題目": "根據American College of Radiology (ACR) 所訂定的BI- RADS (Breast Imaging-Reporting and Data System) Category，乳房攝影的結果在以下的評分中，那些情形應 建議病人接受生檢(Biopsy)？",
        "選項": [
            "A. BI-RADS 1",
            "B. BI-RADS 2",
            "C. BI-RADS 3",
            "D. BI-RADS 4",
            "E. BI-RADS 5"
        ],
        "答案": "DE",
        "出處": "BI-RADS (Breast Imaging-\nReporting and Data System) 5th\nedition: Classification"
    },
    {
        "題別": "複",
        "題號": "56",
        "題目": "早期乳癌病人接受乳房保留手術(Breast conserving surgery, BCS)，前哨淋巴結手術(Sentinel Lymph Node Biopsy, SLNB)發現有淋巴結轉移，需滿足下列那些條件可 不繼續進行腋下淋巴腺擴清術(Axillary Lymph Node Dissection, ALND)？",
        "選項": [
            "A. cT1-T2, cN0",
            "B. Preoperative chemotherapy",
            "C. No preoperative chemotherapy",
            "D. 1-2 positive Sentinel lymph nodes",
            "E. WBRT(Whole breast radiotherapy) planned"
        ],
        "答案": "ACDE",
        "出處": "NCCN Guidelines Version 2.2024\nBINV-D"
    },
    {
        "題別": "複",
        "題號": "57",
        "題目": "早期乳癌病人接受全乳切除手術(Mastectomy)，前哨淋巴 結手術(Sentinel Lymph Node Biopsy, SLNB)發現有淋巴結 轉移，需滿足下列那些條件可考慮不繼續進行腋下淋巴腺 擴清術(Axillary Lymph Node Dissection, ALND)？",
        "選項": [
            "A. cT1-T2, cN0",
            "B. Preoperative chemotherapy",
            "C. No preoperative chemotherapy",
            "D. 1-2 positive Sentinel lymph nodes",
            "E. Adjuvant RT planned with intentional inclusion of undissected axilla at risk"
        ],
        "答案": "ACDE",
        "出處": "Guidelines Version 2.2024 BINV-D"
    },
    {
        "題別": "複",
        "題號": "58",
        "題目": "以下那些基因檢測模組是在治療指引中被推薦可應用在乳 癌輔助治療的選擇？",
        "選項": [
            "A. Oncotype DX (21-gene RT-PCR assay)",
            "B. MammaPrint (70-gene assay)",
            "C. Prosigna (50-gene assay)",
            "D. EndoPredict (12-gene assay)",
            "E. Breast Cancer Index (BCI)"
        ],
        "答案": "ABCDE",
        "出處": "NCCN Guidelines Version 2.2024\nBINV-N"
    },
    {
        "題別": "複",
        "題號": "59",
        "題目": "可手術乳癌病人有腋下淋巴結轉移接受新輔助化療，化療 後影像學檢查無明顯轉移的淋巴結 ，規劃進行前哨淋巴結 切片手術（Sentinel Lymph Node Biopsy, SLNB)，以下原 則何者是降低偽陰性結果的建議處置？",
        "選項": [
            "A. Dual tracer",
            "B. Single tracer",
            "C. 取得三顆以上前哨淋巴結(Sentinel Lymph node)",
            "D. 取得二顆以上前哨淋巴結(Sentinel Lymph node)",
            "E. 摘除化療前已證實轉移並標記的淋巴結"
        ],
        "答案": "ACE",
        "出處": "NCCN Guidelines Version 2.2024\nBINV-D\nCaudle AS, et al. J Clin Oncol\n2016;34:1072-1078."
    },
    {
        "題別": "複",
        "題號": "60",
        "題目": "以下那些情況可只做前哨淋巴結切片手術（Sentinel Lymph Node Biopsy, SLNB) 而不需繼續進行腋下淋巴腺擴 清術(Axillary Lymph Node Dissection, ALND)？",
        "選項": [
            "A. 術前cT1-2N0的乳癌病人，前哨淋巴結手術没有轉移",
            "B. 術前cT1-2N0的病人接受乳房保留手術併術後放射線治 療，前哨淋巴結有2顆淋巴腺轉移取得二顆以上前哨淋巴結 (Sentinel Lymph node)",
            "C. 術前cT1-2N0的病人接受乳房全切除手術，前哨淋巴結 有1顆癌細胞微轉移（micrometastasis)",
            "D. 可手術乳癌病人有腋下淋巴結轉移接受新輔助化療，化 療後影像學檢查無明顯轉移的淋巴結 ，摘取3顆前哨淋巴結 皆無轉移的癌細胞",
            "E. Inflammatory breast cancer局部晚期乳癌病人在接受術 前化療後影像上無明顯液下淋巴腺腫大"
        ],
        "答案": "ABCD",
        "出處": "NCCN Guidelines Version 2.2024\nBINV-D IBC-2"
    }
]